Pacific Biosciences of California, Inc.
PACB
Price:
$1.58
Market Cap:
$430.60M
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and s...[Read more]
Industry
Medical - Devices
IPO Date
2010-10-27
Stock Exchange
NASDAQ
Ticker
PACB
The ROE as of September 2024 (TTM) for Pacific Biosciences of California, Inc. (PACB) is -61.44%
According to Pacific Biosciences of California, Inc.’s latest financial reports and current stock price. The company's current ROE is -61.44%. This represents a change of 263.14% compared to the average of -16.92% of the last 4 quarters.
Pacific Biosciences of California, Inc. (PACB) Historical ROE (quarterly & annually)
How has PACB ROE performed in the past?
The mean historical ROE of Pacific Biosciences of California, Inc. over the last ten years is -70.07%. The current -61.44% ROE has changed -12.32% with respect to the historical average. Over the past ten years (40 quarters), PACB's ROE was at its highest in in the December 2020 quarter at 22.34%. The ROE was at its lowest in in the September 2019 quarter at -57.09%.
Average
-70.07%
Median
-70.30%
Minimum
-141.70%
Maximum
8.76%
Pacific Biosciences of California, Inc. (PACB) ROE by Quarter and Year
Discovering the peaks and valleys of Pacific Biosciences of California, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 130.24%
Maximum Annual ROE = 8.76%
Minimum Annual Increase = -361.42%
Minimum Annual ROE = -141.70%
| Year | ROE | Change |
|---|---|---|
| 2023 | -43.74% | -17.08% |
| 2022 | -52.75% | 130.24% |
| 2021 | -22.91% | -361.42% |
| 2020 | 8.76% | -106.18% |
| 2019 | -141.70% | 57.59% |
| 2018 | -89.92% | -16.02% |
| 2017 | -107.07% | 21.89% |
| 2016 | -87.84% | 103.81% |
| 2015 | -43.10% | -64.20% |
| 2014 | -120.40% | 5.05% |
Pacific Biosciences of California, Inc. (PACB) Average ROE
How has PACB ROE performed in the past?
The current ROE of Pacific Biosciences of California, Inc. (PACB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-39.80%
5-year avg
-50.47%
10-year avg
-70.07%
Pacific Biosciences of California, Inc. (PACB) ROE vs. Peers
How is PACB’s ROE compared to its peers?
Pacific Biosciences of California, Inc.’s ROE is less than Invitae Corporation (472.72%), greater than Twist Bioscience Corporation (-38.91%), greater than Intellia Therapeutics, Inc. (-49.70%), greater than CRISPR Therapeutics AG (-13.85%), greater than Editas Medicine, Inc. (-62.61%),
| Company | ROE | Market cap |
|---|---|---|
| 472.72% | $5.44M | |
| -38.91% | $2.15B | |
| -49.70% | $2.00B | |
| -13.85% | $3.80B | |
| -62.61% | $296.09M |
Build a custom stock screener for Pacific Biosciences of California, Inc. (PACB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacific Biosciences of California, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pacific Biosciences of California, Inc. (PACB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pacific Biosciences of California, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pacific Biosciences of California, Inc.'s ROE?
How is the ROE calculated for Pacific Biosciences of California, Inc. (PACB)?
What is the highest ROE for Pacific Biosciences of California, Inc. (PACB)?
What is the 3-year average ROE for Pacific Biosciences of California, Inc. (PACB)?
What is the 5-year average ROE for Pacific Biosciences of California, Inc. (PACB)?
How does the current ROE for Pacific Biosciences of California, Inc. (PACB) compare to its historical average?